Anja van der Hout|Cornelia F. van Uden?Kraan|Birgit I. Witte|Veerle M.H. Coupé|Femke Jansen|C. René Leemans|Pim Cuijpers|Lonneke V. van de Poll?Franse|Irma M. Verdonck?de Leeuw
Efficacy, cost-utility and reach of an eHealth self-management application 'Oncokompas' that helps cancer survivors to obtain optimal supportive care: study protocol for a randomised controlled trial
Vrije Universiteit Amsterdam|Vrije Universiteit Amsterdam|Amsterdam UMC Location VUmc|Amsterdam UMC Location VUmc|Amsterdam UMC Location VUmc|Amsterdam UMC Location VUmc|EMGO Institute for Health and Care Research|Netherlands Comprehensive Cancer Organisation|EMGO Institute for Health and Care Research
cancer survivors deal wide range physical symptoms psychological social existential concerns lifestyle issues related cancer treatment therefore essential access optimal supportive care services ehealth selfmanagement application oncokompas developed support cancer survivors need turn advice guidance well increase knowledge availability optimal support randomised controlled trial conducted assess efficacy costutility reach oncokompas ehealth selfmanagement application compared care usual among cancer survivorsadult cancer survivors diagnosed breast colorectal head neck cancer lymphoma 3 months 5 years since curative treatment included total 544 cancer survivors randomly assigned intervention group waitlist control group primary outcome measure patient activation secondary outcome measures include selfefficacy personal control perceived patientphysician interaction need supportive care mental adjustment cancer healthrelated quality life furthermore costutility outcomes assessed reach defined percentage cancer survivors get access oncokompas within context trial questionnaires administered baseline postintervention 3 6month followupin study evaluate efficacy costutility oncokompas among cancer survivors well reach oncokompas essential first steps translation research practice contribute sustainable adoption implementation maintenance evidencebased oncokompasnetherlands trial register identifier ntr5774 registered 8 march 2016